Results

eNauka >  Results >  Diroximel fumarate (DRF) in patients with relapsing-remitting multiple sclerosis: interim safety and efficacy results from the Phase 3 EVOLVE-MS-1 study
Title : Diroximel fumarate (DRF) in patients with relapsing-remitting multiple sclerosis: interim safety and efficacy results from the Phase 3 EVOLVE-MS-1 study
Authors: Bergh, Florian Then; Singer, BA; Drulovic, Jelena S  ; Bidollari, I; Chen, Hailu; Englishby, R; Hanna, Jerome; Kandinov, Boris; Lopez-Bresnahan, Maria; Leigh-Pemberton, Richard;
Miller, Catherine; Mokliatchouk, O; Shafer, SJ;
Issue Date: 2019
Publication: MULTIPLE SCLEROSIS JOURNAL
ISSN: 1352-4585 Multiple Sclerosis Search Idenfier
Type: Conference Paper
Collation: vol. 25 str. 861-862
WoS-ID: 000485303103349
URI: https://enauka.gov.rs/handle/123456789/827905
Project: Biogen/Alkermes
Biogen (Cambridge, MA, USA)
Alkermes (Waltham, MA, USA)
Biogen
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
Mp. category will be shown later

Find the DOI

Google ScholarTM

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.